Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Anteris Technologies.
RELATED STOCKHEAD STORIES
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
ASX Health Stocks: Polynovo leaps 12pc after coming out of trading halt, gets FDA approval
Health & Biotech
ASX Health Stocks: Lumos down 65pc on FDA rejection; and is Hexima belly-up after Phase 2 readout?
Health & Biotech
ASX Health Stocks: Anteris implants its novel aortic valve DurAVR into 8 more patients
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
Health & Biotech
Mesoblast has long been the one poster child for stem cell therapy. Now Cynata and other ASX stocks have emerged
Health & Biotech
Here are the ASX heart stocks fighting the number one killer disease in humans
Health & Biotech
ASX Health: Twiggy Forrest’s investment fund takes a stake in this ASX cannabis stock
News
10 at 10: These ASX stocks have attracted the most curiosity from the market this morning
News
ASX Capital Raise Roundup: Arise, Sir Lithium
Health & Biotech
ASX Health Stocks: Hydrix implants world’s first Guardian heart attack alert system
News
ASX Capital Raise Roundup: Plenty of activity to report but IPOs remain weak
Tech
ASX Tech Stocks: Stadium software player MSL Solutions (ASX:MSL) jumps 12.5% backed by impressive partnerships
Tech
ASX Tech Stocks: Electro Optic Systems (ASX:EOS) up 4.81pc with cool laser technology that can break up space debris
News
Market highlights and 5 ASX small caps to watch on Tuesday
Health & Biotech
New breakthrough in stem cells research paves the way for ASX regenerative medicine stocks
News